Identification and Characterization of Antiterminator RNAs
抗终止子 RNA 的鉴定和表征
基本信息
- 批准号:7192384
- 负责人:
- 金额:$ 20.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-02-01 至 2011-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAttenuatedBacteriophage HK022Bacteriophage lambdaBacteriophagesBase PairingBinding SitesBiomedical ResearchComparative Genomic AnalysisComplexComputer SimulationDNA-Directed RNA PolymeraseDevelopmentDiseaseDrug DesignElementsEnvironmentEscherichia coliEvolutionFamilyGene ExpressionGene Expression RegulationGenesGeneticGenetic TranscriptionGenomeGoalsIn VitroInstitutionKentuckyLearningMediatingMissionModelingMutationNumbersProcessProteinsRNARNA SequencesReadingResearchResearch Project GrantsSiteStructureStudentsTherapeutic AgentsTranscriptTranscription ElongationUniversitiesVirulenceantiterminationbasecomputer generateddesignin vivomemberprogramsresearch studyrhotranscription termination
项目摘要
DESCRIPTION (provided by applicant): This proposal accomplishes the AREA program objectives of: 1) supporting meritorious research; 2) exposing undergraduates to research; and 3) strengthening the research environment in non-research intensive universities. The goal of this project is to understand a unique mechanism of transcription elongation control originally discovered in the bacteriophage HK022. Most members of the lambda phage family use phage-encoded proteins to promote early gene expression by suppressing transcription termination. HK022 does not encode an antitermination protein but relies instead on the direct interaction of sites in the nascent transcript with RNA polymerase. The specific hypothesis is that the activity of RNA-based antiterminators depends upon the recognition of sequence and structural information in the nascent transcript by RNA polymerase. This hypothesis is based upon previous studies that 1) have shown that mutations that disrupt base pairing in the RNA reduce antitermination and secondary mutations that re-establish base pairing restore terminator read through 2) interchanging segments of antiterminator RNAs drastically affects activity, and 3) RNA-mediated antitermination is blocked by mutations in the beta prime subunit of E. coli RNA polymerase. The goal of this proposal is to identify the required sequence and structural elements of RNA based antiterminators. The specific aims are: 1) to identify additional examples of antiterminator RNAs in lambdoid phages; 2) to use in vivo, in vitro and in silico approaches to determine the structurally and functionally important features of the newly identified antiterminator RNAs; and 3) to complete the annotation of two new phage genomes that possess RNA-based antiterminators. The antiterminator sequences discovered in HK022 provide unique examples of RNAs that control gene expression by directly modifying the transcription apparatus. Unusual modes of gene regulation are potential targets for drug design. Therefore, a better understanding of antiterminator RNAs and their recognition by RNA polymerase may facilitate the discovery or development of therapeutic agents capable of altering the expression of virulence genes and thus attenuating disease processes. Western Kentucky University aspires to be the best comprehensive public institution in Kentucky and among the best in the nation. This project supports this mission and will enhance the research environment at Western by providing undergraduate students with numerous opportunities to learn the fundamentals of biomedical research while exploring a unique mechanism of gene expression control. The antiterminator sequences discovered in phage HK022 provide unique examples of RNAs that control gene expression by directly modifying the transcription apparatus. Unusual modes of gene regulation are potential targets for drug design. Therefore, a better understanding of antiterminator RNAs and their recognition by RNA polymerase may facilitate the discovery or development of therapeutic agents capable of altering the expression of virulence genes and thus attenuating disease processes.
描述(由申请人提供):本提案实现了区域计划的目标:1)支持有价值的研究;2)让本科生参与研究;3)加强非研究型大学的研究环境。该项目的目标是了解最初在噬菌体HK022中发现的转录延伸控制的独特机制。大多数λ噬菌体家族成员使用噬菌体编码蛋白通过抑制转录终止来促进早期基因表达。HK022不编码抗终止蛋白,而是依赖于新生转录物中的位点与RNA聚合酶的直接相互作用。具体假设是基于RNA的抗终止子的活性取决于RNA聚合酶对新生转录物序列和结构信息的识别。这一假设是基于先前的研究:1)研究表明,破坏RNA中碱基配对的突变会减少抗终止,而重新建立碱基配对的二次突变会恢复通过末端读取的终止;2)抗终止RNA的互换片段会极大地影响活性;3)RNA介导的抗终止被大肠杆菌RNA聚合酶β prime亚基的突变阻断。本提案的目标是确定RNA为基础的抗终止子所需的序列和结构元件。具体目的是:1)在小细胞样噬菌体中鉴定更多的抗终结者rna;2)利用体内、体外和计算机方法确定新鉴定的抗终结者rna在结构和功能上的重要特征;3)完成两个具有基于rna的抗终止子的噬菌体基因组的注释。在HK022中发现的抗终止序列提供了通过直接修饰转录装置来控制基因表达的rna的独特例子。不寻常的基因调控模式是药物设计的潜在目标。因此,更好地了解抗终结者RNA及其被RNA聚合酶识别可能有助于发现或开发能够改变毒力基因表达从而减轻疾病过程的治疗剂。西肯塔基大学立志成为肯塔基州最好的综合性公共机构,在全国名列前茅。该项目支持这一使命,并将通过为本科生提供大量学习生物医学研究基础的机会,同时探索基因表达控制的独特机制,从而改善西部大学的研究环境。在噬菌体HK022中发现的抗体序列提供了通过直接修饰转录装置来控制基因表达的rna的独特例子。不寻常的基因调控模式是药物设计的潜在目标。因此,更好地了解抗终结者RNA及其被RNA聚合酶识别可能有助于发现或开发能够改变毒力基因表达从而减轻疾病过程的治疗剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rodney Allen King其他文献
Rodney Allen King的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rodney Allen King', 18)}}的其他基金
RNA-BASED MECHANISMS OF TRANSCRIPTION ELONGATION CONTROL
基于 RNA 的转录延伸控制机制
- 批准号:
8360107 - 财政年份:2011
- 资助金额:
$ 20.48万 - 项目类别:
RNA-BASED MECHANISMS OF TRANSCRIPTION ELONGATION CONTROL
基于 RNA 的转录延伸控制机制
- 批准号:
7960112 - 财政年份:2009
- 资助金额:
$ 20.48万 - 项目类别:
RNA-BASED MECHANISMS OF TRANSCRIPTION ELONGATION CONTROL
基于 RNA 的转录延伸控制机制
- 批准号:
7720136 - 财政年份:2008
- 资助金额:
$ 20.48万 - 项目类别:
RNA-BASED MECHANISMS OF TRANSCRIPTION ELONGATION CONTROL
基于 RNA 的转录延伸控制机制
- 批准号:
7610390 - 财政年份:2007
- 资助金额:
$ 20.48万 - 项目类别:
RNA-BASED MECHANISMS OF TRANSCRIPTION ELONGATION CONTROL
基于 RNA 的转录延伸控制机制
- 批准号:
7381780 - 财政年份:2006
- 资助金额:
$ 20.48万 - 项目类别:
RNA-BASED MECHANISMS OF TRANSCRIPTION ELONGATION CONTROL
基于 RNA 的转录延伸控制机制
- 批准号:
7171002 - 财政年份:2005
- 资助金额:
$ 20.48万 - 项目类别:
相似海外基金
A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
- 批准号:
24K02286 - 财政年份:2024
- 资助金额:
$ 20.48万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
- 批准号:
2420924 - 财政年份:2024
- 资助金额:
$ 20.48万 - 项目类别:
Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 20.48万 - 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
- 批准号:
10742028 - 财政年份:2023
- 资助金额:
$ 20.48万 - 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
- 批准号:
BB/X017540/1 - 财政年份:2023
- 资助金额:
$ 20.48万 - 项目类别:
Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
- 批准号:
LP210301365 - 财政年份:2023
- 资助金额:
$ 20.48万 - 项目类别:
Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
- 批准号:
10730832 - 财政年份:2023
- 资助金额:
$ 20.48万 - 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
- 批准号:
10659841 - 财政年份:2023
- 资助金额:
$ 20.48万 - 项目类别:
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
- 批准号:
576545-2022 - 财政年份:2022
- 资助金额:
$ 20.48万 - 项目类别:
Idea to Innovation
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
- 批准号:
BB/V016067/1 - 财政年份:2022
- 资助金额:
$ 20.48万 - 项目类别:
Research Grant